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Phagocytosis of apoptotic cells is a key step in the
completion of programmed cell death that occurs
throughout life in multicellular organisms. The molecu-
lar events involved in clearance of apoptotic cells are
just beginning to be elucidated. Recently, CED-6, an
adapter protein involved in engulfment has been cloned
in Caenorhabditis elegans and in humans. CED-6 is com-
posed of a phosphotyrosine-binding (PTB) domain and a
proline-rich C-terminal domain with no apparent cata-
lytic domain. Since PTB domains, originally identified
in Shc, mediate intracellular signaling downstream of
cell surface receptors, CED-6 has also been proposed to
mediate intracellular signals leading to engulfment. In
this report, we demonstrate that CED-6 dimerizes
through a leucine zipper domain that is immediately
adjacent to the PTB domain. Several lines of evidence
based on co-immunoprecipitation studies, yeast two-hy-
brid assays, and gel filtration studies suggest that CED-6
exists as a dimer in vivo. Through mutational analyses,
we show that the leucine zipper is necessary and suffi-
cient for CED-6 dimerization and that this dimerization
is conserved among C. elegans, rodent, and human
CED-6 proteins. We propose that dimerization may have
unique implications for ligand binding via CED-6 and its
function during the phagocytosis of apoptotic cells.
Apoptosis of specific cell populations and the subsequent
phagocytosis of apoptotic cells are critical events that occur
throughout the lifespan of organisms (1). Clearance of dead
cells is mediated by professional phagocytes such as macro-
phages and dendritic cells, as well as by nonprofessional phago-
cytes within certain tissues (2–4). Removal of apoptotic cells
occurs very rapidly in vivo and helps to prevent secondary
necrosis and the release of potentially harmful contents from
dying cells (5). In humans, the failure to properly remove
apoptotic cells has been implicated in certain types of chronic
inflammation. Engulfment of apoptotic cells is mediated by the
recognition of specific markers on dying cells by receptors on
the phagocytic cells (6, 7). The subsequent intracellular signals
delivered within the phagocyte through these recognition re-
ceptors are thought to mediate the cytoskeletal rearrangement
and the uptake of apoptotic cells. Although several surface
receptors involved in phagocytosis of apoptotic cells have been
recognized, very little is known about intracellular signaling
mediated by these receptors and the precise molecular events
regulating the execution of engulfment (2, 4, 5).
Recently, genetic studies in Caenorhabditis elegans have
identified at least six genes that are involved in clearance of
apoptotic cells (1, 8). These six genes fall into two partially
redundant complementation groups and include ced-1, ced-6,
and ced-7 in one group and ced-2, ced-5, and ced-10 in another
(9). The cloning of the ced-6 gene by Liu and Hengartner (10)
showed that the ceCED-61 protein resembles an adapter pro-
tein with an N-terminal phosphotyrosine-binding (PTB) do-
main, and a C-terminal proline-rich region with no apparent
catalytic domain. The CED-6 PTB domain is highly homologous
to the “classical” PTB domains originally identified in other
mammalian signaling proteins such as Shc. PTB domains of
proteins such as Shc, Numb, FE65, and X11 have been shown
to mediate protein-protein as well as protein-phospholipid in-
teractions (11–14). Because many PTB domain-containing pro-
teins have been shown to function downstream of cell surface
receptors, it was proposed that CED-6 may function as a sig-
naling adapter protein during phagocytosis of apoptotic cells
(10).
Recently, the human and Drosophila homologues of ced-6
have also been cloned (15, 16). Alignment of the amino acid
sequences of C. elegans, Drosophila, and human CED-6 pro-
teins demonstrates that the N-terminal PTB domain is evolu-
tionarily conserved, whereas the C-terminal proline-rich se-
quences are less well conserved (16). Since the overall domain
organization of these proteins are the same, this suggested an
evolutionarily conserved function for CED-6. Consistent with
this, overexpression of hCED-6 in J774 cells led to enhanced
phagocytosis of apoptotic cells (16). In addition, expression of
hCED-6 partially rescued the defect in apoptotic cell clearance
in worms lacking a functional ceCED-6 protein (15). Although
these data clearly suggest a role for hCED-6 in engulfment of
apoptotic cells, precisely how CED-6 functions during engulf-
ment is not yet understood. At present, the ligands of CED-6
are not known. It is believed that CED-6, via its PTB domain,
may interact with ligands (most likely at the membrane) and
that through other protein-protein interactions, via its C ter-
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minus, CED-6 would mediate downstream signaling leading to
phagocytosis of apoptotic cells.
In this report, we identify and characterize a leucine zipper
domain immediately C-terminal to the CED-6 PTB domain.
Several lines of evidence indicate that this leucine zipper (LZ)
domain mediates dimerization of CED-6 and that the LZ-de-
pendent dimerization is evolutionarily conserved in CED-6 pro-
teins from worm to humans. Since such leucine zipper domains
are not seen in other proteins containing PTB domains such as
Shc, this dimerization is likely to have unique implications for
ligand binding via CED-6 and its signaling function during
engulfment of apoptotic cells.
EXPERIMENTAL PROCEDURES
Plasmids—All hCED-6 constructs were obtained by PCR and cloned
into the eukaryotic expression vectors pEBG (for expression as a glu-
tathione S-transferase (GST) fusion protein) and pEBB-HA (for expres-
sion of hemagglutinin (HA) tagged proteins) using 59-NdeI and 39-NotI
restriction sites (17). The original template for hced-6 has been de-
scribed (16). The NdeI site within the coding sequence of the original
hced-6 clone was destroyed by a silent mutation using a PCR-based
mutagenesis strategy. The internal primers used were 59-GAT AAA
ACT GAC AAG AGG ATA TTC ACT TTC ATT TGC AAA GAT TCT
GAG TCA AAT AAA CAT TTG-39 and 59-CAA ATG TTT ATT TGA CTC
AGA ATC TTT GCA AAT GAA AGT GAA TAT CCT CTT GTC AGT TTT
ATC-39. This construct was used as the template for all further hCED-6
constructs. Mutation of the central prolines (L174P/L183P) were gen-
erated using a PCR-based approach with internal primers 59-GAA TCC
AAG ACC CCG AAA CAG AAA ATA TGG AAC CCA AAA AT-39 and
59-CTT GTA CTT TAT TTT TGG GTT CCA TAT TTT CTG TTT CGG
GGT CTT G-39. The C. elegans ced-6 in the pEBG and pEBB-HA
plasmids were generated by PCR using the cDNA that has been previ-
ously described (10). ceCED-6 was also cloned into pEBG and pEBB-HA
vectors using the 59-NdeI and 39-NotI sites. The leucine to proline
mutations (L215P and L208P/L215P) were carried out using a similar
approach as described above for human CED-6 using 59-AAG AAA AAG
ATT GTG GAG CCT GAA ACC GAG AAT C-39 to mutate leucine 215
and 59-GCT CCA CAA TCT TTT TCT TTG GAA TGT ATA TTT GCT
TC-39 to mutate leucine 208. All regions that were cloned by PCR were
sequenced to ensure fidelity.
Cell Culture and Transfection—Human embryonic kidney 293T cells
and COS-7 cells were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 5% bovine calf serum, 5% fetal calf serum, and
penicillin/streptomycin/glutamine (Life Technologies, Inc.). The Chi-
nese hamster ovary fibroblast cell line LR73 (18) was cultured in Alpha-
modified Eagle’s medium supplemented with 10% fetal calf serum and
penicillin/streptomycin/L-glutamine. 293T cells were transfected by the
calcium phosphate method (5 Prime 3 3 Prime, Inc., Boulder, CO).
COS-7 cells were transfected using Superfect (Qiagen, Valencia, CA)
according to manufacturer’s recommendation. All transient transfec-
tions were performed using 2–5 mg of the appropriate expression plas-
mid. LR73 cells were stably transfected by the calcium phosphate
method. Briefly, 20 mg of the appropriate expression plasmid (linearized
with SphI), was co-transfected with 0.5 mg of puromycin resistance
gene-expressing pApuro plasmid (linearized with NotI), as a selection
marker. Cells were plated at different concentrations in growth media
containing 7 mg/ml of puromycin, and single clones were isolated for
further studies.
Immunoprecipitations and Immunoblotting—Cells were lysed on the
tissue culture plates with lysis buffer (50 mM Tris pH 7.6, 150 mM NaCl,
10 mM each aprotinin, leupeptin, pepstatin, AEBSF, 10 mM sodium
fluoride, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate,
and 1% Nonidet P-40). GST-tagged proteins were precipitated with
glutathione-Sepharose (Amersham Pharmacia Biotech). Anti-HA im-
munoprecipitations were performed with using 12CA5 supernatant or
H-7 anti-HA antibodies pre-bound to protein A or protein A-protein
G-agarose conjugates (Santa Cruz Biotechnology Inc., Santa Cruz, CA).
Precipitates were washed four times with buffer containing 20 mM Tris,
pH 7.6, 150 mM NaCl, 1 mM each aprotinin, leupeptin, pepstatin,
AEBSF, 5 mM sodium fluoride, 1 mM sodium orthovanadate, and 0.1%
Nonidet P-40. Antibodies for Western blotting HA and GST-tagged
proteins were purchased from Santa Cruz Biotechnology. Secondary
antibodies conjugated to horseradish peroxidase were purchased from
Amersham Pharmacia Biotech. Antibody EP990445 to hCED-6 was
generated by immunizing rabbits with a peptide corresponding to
amino acids 31–44 from hCED-6. Monoclonal anti-Grb2 and anti-Shc
antibodies were obtained from Transduction Labs (Lexington, KY). All
immunoblots were developed using enhanced chemiluminescence
(Pierce).
Two-hybrid Assay—The two-hybrid system was purchased from
CLONTECH Laboratories (Palo Alto, CA). hced-6 was cloned in frame
of the GAL4 DNA-binding domain (pAS2) and GAL4 activation domain
(pGAD424) as a NdeI-SalI fragment. The cloning was verified by DNA
sequencing. Transformation of the Saccharomyces cerevisiae strain
HF7c was done by the lithium acetate method according to the manu-
facturer’s directions. Yeast colonies carrying putative interacting pro-
teins were selected by growth on synthetic minimal media lacking
tryptophan, leucine, adenine, and histidine in the presence of 5 mM
3-amino-1,2,4,-triazole (Sigma) and by screening for b-galactosidase
activity in a filter assay using as a substrate 5-bromo-4-chloro-3-indo-
lyl-b-D-galactopyranoside (X-gal) (Saxon Biochemicals, Hanover,
Germany).
Gel Filtration—Proteins were separated on a 20-ml column of Seph-
adex G-75 (Sigma) equilibrated with 20 mM Tris-HCl, pH 7.6. 2 3 107
LR73 cells were lysed in 200 ml of lysis buffer, filtered through a
0.22-mm spin filter (Fisher), and loaded onto the column. The first 4 ml
of void volume was discarded. 50 fractions containing 500 ml were
collected. Fractions were separated by SDS-PAGE and immunoblotted
with the indicated antibodies.
RESULTS
Dimerization of hCED-6—As part of our studies to under-
stand human CED-6 function during phagocytosis of apoptotic
cells, we generated hCED-6 constructs carrying two different
epitope tags (HA-tagged or GST-tagged hCED-6) and expressed
them transiently in COS-7 cells. Following glutathione-Sepha-
rose (GSH) precipitation, we observed that the HA-tagged
hCED-6 was precipitated with GST-tagged hCED-6 as deter-
mined by anti-HA immunoblotting (Fig. 1). In the same exper-
iment, the GST tag alone did not precipitate the HA-hCED-6.
Conversely, immunoprecipitation of HA-tagged hCED-6 (with
anti-HA antibodies) co-precipitated the GST-tagged hCED-6
(see Fig. 5 below). These data suggested that hCED-6 proteins
can form dimers/oligomers in cells. Expression of these proteins
in 293T cells yielded similar results (data not shown).
FIG. 1. Co-precipitation hCED-6 carrying two different tags.
Plasmids encoding GST-tagged hCED-6 or the GST tag alone were
co-transfected with HA-tagged hCED-6 into COS-7 cells. Following
GSH precipitation, the bound proteins were separated by SDS-PAGE
and immunoblotted with anti-HA antibodies (left upper panel). Similar
amounts of GST alone and GST-hCED-6 were precipitated in both lanes
(left lower panel) as determined by anti-GST immunoblotting. Compa-
rable expression of HA and GST-tagged proteins in the transfected COS
cells was confirmed in total cell lysates (right panels, lanes 3 and 4).
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We also tested hCED-6 for self-interaction in a yeast two-
hybrid assay. hCED-6 was cloned into appropriate yeast two-
hybrid plasmids and expressed as a fusion with the GAL4
DNA-binding domain (GAL4-BD) or GAL4 activation domain
(GAL4-AD). After transformation of appropriate yeast strain
with these plasmids, the ability of yeast to grow on histidine-
deficient media and b-galactosidase enzyme activity were
tested (both of which are dependent on the interaction between
the two hCED-6 fusion proteins). As shown in Table I, although
GAL4-BD or Gal4-AD alone fused to hCED-6 were not suffi-
cient, co-expression of the two constructs provided His auxo-
trophy and b-galactosidase activity. These data again suggest
that hCED-6 can also dimerize in the heterologous yeast
system.
Identification by Sequence Analysis of a Conserved Leucine
Zipper within CED-6—By aligning the predicted PTB regions
of hCED-6 with Shc, we observed that the PTB domain of
hCED-6 appears to end at amino acid 150 (which corresponds
to amino acid 204 of human p52Shc, consistent with the C
terminus of the Shc-PTB domain determined by NMR). How-
ever, comparison of CED-6 protein sequence among the differ-
ent species indicated that a high degree of homology exists up
to amino acid 200 of hCED-6. Interestingly, the region between
amino acid 150 and 200 of hCED-6 contains four leucines that
are spaced seven residues apart, a feature characteristic of
leucine zippered coiled-coil domains (19). Previously, leucine
zipper domains have been identified in many transcription
factors and a few cytoplasmic proteins and have been found to
play a role in dimerization/multimerization of proteins (19).
Thus, we hypothesized that hCED-6 could dimerize/oligomer-
ize through this leucine zipper like sequence.
To better characterize the putative LZ region, we analyzed
the sequences of hCED-6 and ceCED-6 through the program,
Multicoil (20). This program accurately predicts the oligomer-
ization state of protein sequences based on the position of
specific hydrophobic and charged amino acids as well as pair-
wise residue interactions. As shown in Fig. 2A, the Multicoil
program predicted the existence of a coiled-coil domain capable
of forming a parallel side-by-side homodimer in both hCED-6
and ceCED-6. This coiled-coil is immediately C-terminal to the
PTB domain homology. Analysis of a number of other PTB
domain-containing proteins such as Shc, Numb, and Dab-1 in
the Multicoil program failed to show a similar coiled-coil motif
in these other proteins. The alignment of the human and
ceCED-6 leucine zipper region and the key features of the
sequence are shown in Fig. 2B. Helical wheel representation of
the hCED-6 coiled-coil showed that the four heptad leucines
align correctly in a side-by-side dimer of hCED-6 molecules and
that specifically spaced hydrophobic residues create a hydro-
phobic surface that can mediate dimerization (Fig. 2C).
Leucine Zipper Region Is Necessary and Sufficient to Mediate
Dimerization of hCED-6—To determine whether the predicted
leucine zipper region is necessary and sufficient for dimeriza-
tion of hCED-6, we generated a series of hCED-6 constructs
with deletions or point mutations. These constructs are sche-
matically shown in Fig. 3A. Based on the Multicoil prediction,
the dimerization region extended between amino acids 147 and
202. We tested whether this region alone, expressed as a GST-
tagged protein would be capable of dimerizing with HA-tagged
full-length hCED-6. GST-tagged 147–202 was co-expressed
with HA-hCED-6 in COS cells and precipitated with GSH
beads, and the co-precipitation of HA-hCED-6 was analyzed by
anti-HA immunoblotting. As shown in Fig. 3B, the 147–202
region alone was sufficient to dimerize with full-length
hCED-6. Although the predicted dimerization sequence shows
a shoulder of probability starting from amino acid 147, the
region of highest likelihood is restricted to residues 162–200,
which includes the heptad leucines. When we tested a GST-
tagged protein encoding the region 162–202, this construct
precipitated HA-hCED-6 as efficiently as GST-147–202 or
GST-tagged full-length hCED-6. These data suggested that the
predicted coiled-coil/leucine zipper region is sufficient to medi-
ate dimerization between human CED-6 proteins.
Although the above data indicated that the 162–202 region is
sufficient for dimerization, it did not rule out the possibility
that other regions may also contribute to dimerization between
full-length hCED-6 proteins. To address this, GST-tagged con-
structs containing only the leucine zipper (GST-LZ), the PTB
alone (GST-PTB), or the C terminus alone (GST-C-term) were
individually co-transfected with HA-hCED-6. Following GSH
precipitation, GST-PTB or the GST-C-term failed to co-precip-
itate the HA-hCED-6 protein, whereas the GST-LZ was able to
do so (Fig. 3C). As would be expected from these results, GST-
PTB1LZ was also capable of dimerizing with HA-hCED-6 (Fig.
3B, lane 4).
To further characterize the importance of the leucine zipper
region in the dimerization of the full-length hCED-6 and to
determine the requirement for the leucines, we mutated the
two central leucines to prolines (L176P/L183P) to disrupt the
helical structure. Full-length GST-tagged hCED-6 containing
the two point mutations (L176P/L183P) was co-expressed with
HA-tagged hCED-6. The mutant failed to co-precipitate the
HA-hCED-6, indicating that the dimerization with the wild
type protein was abrogated by the L176P/L183P mutation (Fig.
3D). Taken together, the above data indicate that the leucine
zipper region between amino acids 162–202 of hCED-6 is nec-
essary and sufficient for dimerization.
The ceCED-6 Also Dimerizes through a Leucine Zipper Do-
main—Since a homologous leucine zipper region is also ob-
served in the ceCED-6 sequence, we hypothesized that the
dimerization of CED-6 via the leucine zipper may be evolution-
arily conserved. To test this, we generated constructs encoding
GST-tagged and HA-tagged ceCED-6 (Fig. 4A) and co-ex-
pressed them in 293T cells. Following immunoprecipitation
with anti-HA antibodies, the co-precipitation of GST-ceCED-6
was analyzed by anti-GST immunoblotting. As shown in Fig.
4B, HA-tagged ceCED-6 precipitated the GST-tagged ceCED-6
but not the control GST-Shc. When one or more leucines within
the leucine zipper domain were mutated to prolines (L215P
(lane 4) and L208P/L215P (lane 5)), the co-precipitation of
GST-tagged ceCED-6 with HA-tagged ceCED-6 was abolished.
TABLE I
Interaction of hCED-6 in a yeast two-hybrid assay
The cloning of hCED-6 into the yeast two-hybrid plasmids and the
screening procedure for hybrid formation are described under “Exper-
imental Procedures.” The histidine auxotrophy was assessed by growth
on histidine deficient media, and the b-galactosidase reporter gene
activity was measured by a filter assay using X-gal. The p53 and
SV40-Large T antigen fusions were provided as controls by the manu-
facturer. The dimerization between hCED-6 and the resultant interac-
tion between the GAL4 DNA-binding and activation domains provided
the His auxotrophy and b-galactosidase activity. The hCED-6 binding
to itself was not due to “stickiness” of hCED-6 fused to GAL4-AD or
GAL4-BD, because this was not seen in several other two-hybrid
screens against multiple libraries (data not shown).
GAL4-DNA-binding
domain fusion
GAL4-activation
domain fusion
Histidine
auxotrophy
b-Galactosidase
activity
hCED-6 None 2 2
None hCED-6 2 2
hCED-6 hCED-6 111 111
p53 None 2 2
None SV40-Large T Ag 2 2
p53 SV40-Large T Ag 11 11
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FIG. 2. The coiled-coil region of CED-6 is predicted to mediate dimer formation. A, the hCED-6 and ceCED-6 amino acid sequences were
analyzed using the Multicoil program, which predicts the presence of coiled-coils and the probability for dimer and trimer formation based on
pairwise residue interactions. The probabilities for dimer (blue) and trimer (red) as well as overall score (black) are shown. Although the dimer
probability is very high and considered significant, the trimer peaks at the shoulders of the dimer are due to artifacts of the algorithm and are not
significant. B, alignment of the predicted dimerization regions of hCED-6 and ceCED-6 show heptad repeats with characteristically placed
hydrophobic and charged residues. Identical residues are shown in yellow, and conserved residues are colored blue. The leucines forming the heptad
repeat are shown in red. C, helical wheel prediction of hCED-6 leucine zipper shows that the critical leucines and many hydrophobic residues align
on one side of the wheel to form a dimer interface with another hCED-6 molecule.
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FIG. 3. Dimerization of hCED-6 is mediated through its leucine zipper domain (amino acids 162–202). A, schematic representation of
the hCED-6 constructs generated with GST and HA tags. B, GST-tagged hCED-6 truncations containing the leucine zipper domain were
co-transfected with HA-tagged full-length hCED-6. Following GST precipitation, the co-precipitated HA-hCED-6 proteins were revealed by
anti-HA immunoblotting. Although the predicted dimerization region starts from amino acid 147, a construct starting from amino acid 162 (lane
2) appears to precipitate hCED-6 as efficiently as the construct starting from amino acid 147 (lane 3). Expression of all the transfected proteins
was confirmed by immunoblotting of the total cell lysates (lanes 6–10). C, to test the ability of isolated GST-tagged PTB, LZ, and C terminus to
dimerize with full-length HA-hCED-6, these constructs were transfected into COS cells, precipitated with GSH beads, and analyzed by anti-HA
immunoblotting (upper panels). The levels of GST-tagged proteins were determined by anti-GST immunoblotting (lower panels). Comparable
expression of all transfected proteins in total cell lysates is also shown (lanes 5–8). D, the central two leucines within the leucine zipper domain
were mutated to prolines in full-length hCED-6. GST-tagged (L176/L183P) hCED-6 was co-transfected with HA-hCED-6 and analyzed as described
in the legend to Fig. 1. Comparable levels of the transfected proteins were expressed in total cell lysates (lanes 3 and 4).
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These data demonstrate that the ceCED-6 protein also dimer-
izes through the LZ domain.
Species-specific Dimerization of hCED-6 and ceCED-6—
Since it appeared that the LZ-dependent dimerization of
CED-6 is evolutionarily conserved, we tested whether hCED-6
would be capable of dimerizing with ceCED-6. To explore this
possibility, we co-expressed either HA-tagged or GST-tagged
hCED-6 with the oppositely tagged GST or HA-ceCED-6 in
293T cells. The lysates were precipitated with anti-HA anti-
bodies, and the co-precipitation of the GST-tagged protein was
determined by anti-GST immunoblotting. As shown in Fig. 5,
HA-tagged ceCED-6 was unable to cross-dimerize with GST-
hCED-6 but was fully capable of dimerizing with GST-tagged
ceCED-6. Likewise, hCED-6, although capable of dimerizing to
itself, was unable to cross-dimerize with ceCED-6. These re-
sults underscore the high specificity for leucine zipper-depend-
ent interactions in CED-6. In some experiments, after long
exposure, we detected bands corresponding to ceCED-6 co-
precipitating with hCED-6. Because these were extremely
weak compared with the strong bands observed with CED-6
from the same species, we conclude that the cross-species in-
teraction is not strong.
Evidence for Dimerization of Rodent CED-6—The presence
of a conserved leucine zipper domain from worms to humans
suggested an evolutionarily important role for this domain in
CED-6 function that may also be conserved in other species.
Thus, we predicted that a similar dimerization also occurs in
the rodent CED-6 protein. We have observed that the anti-
human CED-6 antibodies (generated against a peptide se-
quence derived from the hCED-6 PTB domain) also recognized
a protein in the hamster LR73 cell line with a molecular weight
similar to that of the human protein (data not shown). It is
noteworthy that the anti-hCED-6 antibodies do not cross-react
with the ceCED-6 (data not shown). Based on this, we hypoth-
esized that the rodent and human proteins are more closely
related and that they may be able to cross-dimerize. This would
also reveal the presence of a similar LZ domain, even though
the hamster ced-6 gene has not yet been cloned. To test this
possibility, we stably expressed GST-hCED-6 in LR73 cells.
These cells were lysed and precipitated with GSH beads, and
the co-precipitation of the endogenous hamster CED-6 was
analyzed by anti-CED-6 immunoblotting. As shown in Fig. 6A,
hamster CED-6 was found to co-precipitate with the GST-
hCED-6 from transfected cells but was not precipitated from
the parental LR73 cells. Expression of GST-LZ alone of hCED-6
in LR73 cells also co-precipitated the endogenous hamster
CED-6 (data not shown).
To further characterize the oligomeric state of endogenous
hamster CED-6, lysates from parental untransfected LR73
cells were fractionated by size exclusion chromatography. The
fractions were separated by SDS-PAGE, and the presence of
hamster CED-6 in the individual fractions was analyzed by
anti-hCED-6 immunoblotting. If endogenous CED-6 in LR73
cells were to exist as a dimer in vivo and assuming a globular
shape, this CED-6 protein would be expected to have a similar
elution pattern as proteins of ;70 kDa. As seen in Fig. 6B, the
peak of hamster CED-6 was observed between fractions 12 and
13. In comparison, the adapter protein Grb2 (predicted molec-
ular mass of 23 kDa) appears in fraction 20. In the same
experiment, the peak of the different isoforms of Shc, p66, p52,
and p48 were seen in fractions 13, 14/15, and 15, respectively.
From these data, we conclude that the endogenous hamster
CED-6 migrates closer to proteins of 65–70 kDa (rather than as
the predicted 35-kDa monomeric form) and also exists as a
dimer in vivo.
FIG. 4. ceCED-6 also dimerizes through a leucine zipper do-
main. A, schematic diagrams of the GST and HA-tagged ceCED-6
constructs and the mutations within the leucine zipper. B, the different
GST-tagged constructs were co-expressed with HA-ceCED-6 in 293T
cells. Following anti-HA immunoprecipitation co-precipitated GST-
tagged proteins were detected by anti-GST immunoblotting. GST-
ceCED-6 can co-precipitate with HA-tagged ceCED-6 (lane 3). When a
single leucine is mutated to proline, the dimerization was abrogated
(lane 4). The levels of HA-ceCED-6 precipitated in the different lanes
are shown in the bottom panel (left). The expression of all the GST-
tagged proteins and HA-tagged proteins in total lysates are shown in
the upper right and lower right panels, respectively (lanes 6–10).
FIG. 5. hCED-6 does not cross-dimerize with ceCED-6. GST-
tagged hCED-6 and ceCED-6 were co-expressed with HA-tagged
hCED-6 and ceCED-6. Following anti-HA immunoprecipitation co-pre-
cipitated GST-tagged proteins were detected with anti-GST immuno-
blotting. GST-ceCED-6 was only co-precipitated by HA-ceCED-6 (lane
2). Likewise, GST-hCED-6 was only co-precipitated by HA-hCED-6
(lane 3). Comparable HA-CED-6 was precipitated in all lanes (left
bottom panel). Expression of the transfected proteins in total lysates is
shown in lanes 7–10 (right panels).
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DISCUSSION
In this report, we demonstrate that CED-6, an adapter pro-
tein involved in phagocytosis of apoptotic cells, can form ho-
modimers in vivo. This CED-6 leucine zipper is necessary and
sufficient for dimerization between CED-6 proteins and is evo-
lutionarily conserved from C. elegans to man. Our data suggest
that CED-6 protein in rodents, although not yet cloned, also
exists as a dimer in vivo and may contain a similar LZ domain
involved in dimerization. To our knowledge, CED-6 is the only
known PTB domain with a contiguous leucine zipper dimeriza-
tion domain and suggests another possible mode of regulation
for ligand binding through the PTB domains. Because the
ligands for CED-6 are currently unknown and the signaling
events involved in phagocytosis of apoptotic cells are just be-
ginning to be elucidated, the dimerization demonstrated here
has implications for regulation of engulfment by CED-6.
The Multicoil program was designed to identify parallel
coiled-coil structures and furthermore distinguish between po-
tential dimers and trimers (20). The predictions are based on
the location of certain types of amino acids in heptad repeats,
with positions within the repeat being denoted as (abcdefg)n.
The positions of characteristic hydrophobic residues in posi-
tions a and d and charged residues in positions e and g within
the heptad determine the coiled-coil. Moreover, Multicoil con-
siders the location and the pairwise interactions between the
residues within the heptad to distinguish a given coiled-coil as
a dimer or trimer (20). Based on this, the coiled-coil within both
the hCED-6 and ceCED-6 proteins were classified as dimers.
Although the shoulders of the coiled-coil regions of both human
and C. elegans proteins were assigned some probability score
for being a trimer, this is most likely an artifact of the algo-
rithm in predicting multimerization at the shoulders of coiled-
coils.2 Moreover, the smaller “bumps” on the Multicoil predic-
tion of the ceCED-6 around amino acids 100 and 450 are not
considered significant because of the low probability scores. In
addition, our mutational analyses of human and ceCED-6 dem-
onstrated that the CED-6 dimerization is dependent on the
leucine zipper motif.
The helical wheel prediction provides further evidence for
dimerization of the coiled-coil region of CED-6. The leucines
and the hydrophobic residues are well aligned on one side of the
coiled-coil, whereas the hydrophilic residues are distributed
evenly throughout the rest of the coiled-coil. This again favors
the formation of a dimer. Moreover, our size exclusion studies
point to CED-6 being a dimer. Despite the caveats of size
exclusion chromatography such as the globular versus elon-
gated shape of the molecule, hamster CED-6 was present in
fractions earlier than those in which p66 and p52 Shc proteins
were seen. The Shc isoforms have a PTB domain and a proline-
rich region analogous to CED-6 but do not have a leucine zipper
region; our previous studies have also demonstrated that Shc
exists only as a monomer (17). Taken together, we conclude
that CED-6 proteins exist as dimers in vivo. However, we
cannot completely rule out the possibility that higher order
oligomers can form, possibly building on the basic block of the
dimer. Since the gel filtration studies suggested that the ma-
jority of CED-6 existed in a homodimeric state, any hamster
CED-6 that forms higher order oligomers would constitute a
small fraction of the total population of hamster CED-6 that is
too small to detect by immunoblotting. An interesting possibil-
ity is that higher order oligomers of rodent CED-6 may form
during an activation event such as recognition of apoptotic cells
or initiation of phagocytosis. It is noteworthy that although our
data support a role for the leucine zipper of CED-6 in ho-
modimerization, the results do not exclude heterodimerization
with other LZ-containing proteins. The above possibilities are
currently under investigation.
Our data also demonstrate that the leucine zipper domain is
necessary and sufficient for dimerization of CED-6 proteins.
The isolated PTB domain or the C-terminal region were unable
to co-precipitate full-length hCED-6, whereas the LZ alone was
very efficient in co-precipitating full-length CED-6. In this re-
gard, we observed that the quantity of HA-CED-6 precipitated
by GST-tagged full-length CED-6 or GST-LZ was indistin-
guishable in many different experiments. Although we cannot
rule out small contribution from other regions of CED-6 to
dimerization of the native protein, these observations and our
data that point mutations of the critical leucines in the LZ
region abolishes the dimerization leads us to propose that the
LZ domain is the primary, if not the only region involved in
dimerization of CED-6. The interactions via the LZ of CED-6
also appeared quite specific. The failure of human or rodent
2 P. Kim, personal communication.
FIG. 6. Rodent CED-6 also can form dimers. A, Chinese hamster
ovarian fibroblast cell line LR73 was stably transfected with GST-
tagged hCED-6. Lysates from parental LR73 cells or the GST-hCED-6
transfected cells were precipitated with GSH beads and the co-precip-
itated hamster CED-6 was detected with antibody to hCED-6, which
cross-reacts with the hamster CED-6 protein. The expression of GST-
hCED-6 is shown in the bottom panel. B, to characterize the oligomeric
state of endogenous CED-6 protein, parental LR73 cells were lysed, and
the proteins were separated by size exclusion chromatography as de-
scribed under “Experimental Procedures.” The fractions were run by
SDS-PAGE, and the presence of CED-6, as well as Shc and Grb2
proteins, were determined by immunoblotting (top, middle, and lower
panels, respectively). Arrows at the bottom indicate the apparent peak
of proteins in the different fractions. The peak of CED-6 was noted
between fractions 12 and 13 (solid triangle), whereas Shc isoforms, p66,
p52, and p46 eluted with peaks between fractions 13, 14/15, and 15 (a,
b, and c, respectively). The peak of Grb2 elution was in fraction 20 (open
triangle). The hamster CED-6 elution profile was more characteristic of
a protein of ;70 kDa (suggestive of a dimer) rather than around 35 kDa
as expected of monomeric CED-6.
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CED-6 protein to dimerize with the worm protein or other PTB
domain-containing proteins such as Shc supports this conclu-
sion. We also observe that stable expression of ceCED-6 in
LR73 cells, unlike human CED-6, fails to co-precipitate the
endogenous hamster CED-6.3
The leucine zipper identified in the human and C. elegans
CED-6 proteins and the data with endogenous hamster pro-
teins suggest that the dimerization domain is evolutionarily
conserved and is likely to be important for CED-6 function.
Genetic studies strongly implied that CED-6 functions as a
signaling adapter protein during engulfment of apoptotic cells
(10). Expression of human ced-6 transgene in worms carrying
mutations of ced-6 partially rescued the defect in clearance of
apoptotic bodies, suggesting that the mechanism of CED-6
function is conserved through evolution (15). Consistent with
this, the overall structural features of CED-6 are highly con-
served in the different species with a PTB domain at its N
terminus, followed by the LZ domain and then the C-terminal
proline-rich domain. Although ligands for CED-6 remain to be
identified, each of its three modules could potentially mediate
interactions with ligands. Based on the known function of other
PTB domains in binding to surface receptors, it is believed that
the PTB domain would mediate interactions with surface re-
ceptors involved in phagocytosis, whereas the C-terminal pro-
line-rich region would interact with intracellular signaling pro-
teins and possibly regulate cytoskeletal reorganization during
engulfment. We favor a model in which the PTB and C-termi-
nal regions interact with ligands, whereas the leucine zipper
mediates homodimerization of CED-6. The LZ-dependent
dimerization may aid the binding of CED-6 to its ligands. For
example, the ligand for the PTB domain may contain more than
one PTB domain-binding site, and dimerization may facilitate
CED-6 binding to such ligands. Alternatively, the affinity of the
PTB domain for its ligand may be low, and dimerization may
enhance such low affinity interactions. PTB domains have
structural homology to pleckstrin homology domains and PTB
domains of Shc and Dab-1 have been shown to bind phospho-
lipids (21, 22). Since the affinity of PTB domains for phospho-
lipids is lower than that for protein ligands (22, 23), the phos-
pholipid interactions would be aided by binding through
dimerized PTB domains.
The dimerization of CED-6 may also improve its ability to
bind to membrane proteins. Since many membrane receptors
function through dimerization, it is possible that CED-6 binds
to membrane receptors involved in phagocytosis after they
dimerize. Alternatively, CED-6 may help to cluster receptors
involved in phagocytosis, and this could be part of the mecha-
nism of engulfment. Some of the surface receptors implicated in
phagocytosis of apoptotic cells can form multimers (e.g. scav-
enger receptors) (24, 25), and further clustering of these al-
ready oligomerized receptors through CED-6 may be a mecha-
nism involved in phagocytosis. Additionally, the C-terminal
domain of CED-6 contains potential SH3-binding sites. SH3
interactions are generally low affinity interactions, and dimer-
ization of CED-6 could allow proteins, which contain multiple
SH3 domains, for example Grb2 and Crk, to bind with higher
affinity. It is interesting to note that the large adapter protein
Cbl, which contains a domain that interacts with phosphoty-
rosines, has been shown to dimerize through a leucine zipper
domain, and this dimerization appears to be required for phos-
phorylation of Cbl (26). Elucidating the precise role of CED-6
dimerization in signaling during phagocytosis of apoptotic cells
may provide important insights to our molecular understand-
ing of this critical biological process.
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